DK1166773T3 - Oplösning indeholdende N-[o-(p-pivaloyloxybenzensulfonylamino)-benzoyl]glycin-mononatriumsalt-tetrahydrat samt medinsk produkt med indhold af denne oplösning - Google Patents

Oplösning indeholdende N-[o-(p-pivaloyloxybenzensulfonylamino)-benzoyl]glycin-mononatriumsalt-tetrahydrat samt medinsk produkt med indhold af denne oplösning

Info

Publication number
DK1166773T3
DK1166773T3 DK01305556T DK01305556T DK1166773T3 DK 1166773 T3 DK1166773 T3 DK 1166773T3 DK 01305556 T DK01305556 T DK 01305556T DK 01305556 T DK01305556 T DK 01305556T DK 1166773 T3 DK1166773 T3 DK 1166773T3
Authority
DK
Denmark
Prior art keywords
solution
pivaloyloxybenzenesulfonylamino
benzoyl
monosodium salt
medical product
Prior art date
Application number
DK01305556T
Other languages
English (en)
Inventor
Akira Takada
Masao Sudoh
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of DK1166773T3 publication Critical patent/DK1166773T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK01305556T 2000-06-29 2001-06-27 Oplösning indeholdende N-[o-(p-pivaloyloxybenzensulfonylamino)-benzoyl]glycin-mononatriumsalt-tetrahydrat samt medinsk produkt med indhold af denne oplösning DK1166773T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000195853 2000-06-29
JP2000195852 2000-06-29

Publications (1)

Publication Number Publication Date
DK1166773T3 true DK1166773T3 (da) 2004-06-07

Family

ID=26594951

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01305556T DK1166773T3 (da) 2000-06-29 2001-06-27 Oplösning indeholdende N-[o-(p-pivaloyloxybenzensulfonylamino)-benzoyl]glycin-mononatriumsalt-tetrahydrat samt medinsk produkt med indhold af denne oplösning

Country Status (19)

Country Link
US (1) US6552082B2 (da)
EP (1) EP1166773B1 (da)
KR (1) KR100725076B1 (da)
CN (1) CN1263736C (da)
AT (1) ATE259218T1 (da)
AU (1) AU782838B2 (da)
BR (1) BR0102604B1 (da)
CA (1) CA2351273C (da)
DE (1) DE60101979T2 (da)
DK (1) DK1166773T3 (da)
ES (1) ES2215856T3 (da)
HU (1) HUP0102699A2 (da)
MX (1) MXPA01006698A (da)
NO (1) NO330296B1 (da)
NZ (1) NZ512486A (da)
PT (1) PT1166773E (da)
RU (1) RU2272623C2 (da)
TR (1) TR200400585T4 (da)
TW (1) TWI246925B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2416600A1 (en) * 2000-07-24 2003-01-20 Ono Pharmaceutical Co., Ltd. Freeze-dried preparation of n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycine monosodium salt tetrahydrate and a process for the maufacture thereof
US20050101633A1 (en) * 2001-05-17 2005-05-12 Takeharu Tonai Remedial agent for myelopathic disease
TW200519080A (en) * 2003-10-03 2005-06-16 Ono Pharmaceutical Co Agent containinf (2R)-2-propyloctanic acid as effective component
CA2707484C (en) 2007-12-04 2021-08-10 Remedy Pharmaceuticals, Inc. Improved formulations and methods for lyophilization and lyophilates provided thereby
KR101247137B1 (ko) * 2011-03-23 2013-04-01 주식회사 엠씨켐 Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법
KR101366706B1 (ko) 2012-12-06 2014-02-24 상명대학교서울산학협력단 Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법
CN104107172B (zh) * 2013-04-18 2017-11-28 上海汇伦生命科技有限公司 西维来司钠注射用冻干粉的制备方法
CN114681435A (zh) * 2020-12-31 2022-07-01 上海汇伦生物科技有限公司 吸入用药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0320253A (ja) 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
CA1340191C (en) 1988-06-13 1998-12-15 Katsuhiro Imaki Derivatives of p-substituted phenyl ester of pivalic acid
IT1242642B (it) * 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.
JP3020253B2 (ja) 1990-05-02 2000-03-15 松下電工株式会社 配線器具の取付枠への取付構造
EP0539223A1 (en) 1991-10-25 1993-04-28 Ono Pharmaceutical Co., Ltd. Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
JPH05194366A (ja) 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法
JP3193597B2 (ja) 1995-07-28 2001-07-30 小野薬品工業株式会社 グリシン誘導体の製造方法
AU5528299A (en) 1998-09-15 2000-04-03 Naeja Pharmaceutical Inc. Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s)
AU6870800A (en) * 1999-09-06 2001-04-10 Ono Pharmaceutical Co. Ltd. Preventive and therapeutic agents for eye diseases

Also Published As

Publication number Publication date
KR100725076B1 (ko) 2007-06-08
RU2272623C2 (ru) 2006-03-27
NO20013223D0 (no) 2001-06-27
ES2215856T3 (es) 2004-10-16
DE60101979D1 (de) 2004-03-18
NO20013223L (no) 2001-12-31
AU782838B2 (en) 2005-09-01
NZ512486A (en) 2001-12-21
KR20020002242A (ko) 2002-01-09
US20020022738A1 (en) 2002-02-21
BR0102604A (pt) 2002-02-13
CA2351273A1 (en) 2001-12-29
TR200400585T4 (tr) 2004-04-21
CN1263736C (zh) 2006-07-12
BR0102604B1 (pt) 2012-06-26
CN1341591A (zh) 2002-03-27
DE60101979T2 (de) 2005-01-05
AU5409201A (en) 2002-03-28
CA2351273C (en) 2010-09-07
MXPA01006698A (es) 2004-07-30
US6552082B2 (en) 2003-04-22
HU0102699D0 (en) 2001-08-28
PT1166773E (pt) 2004-05-31
NO330296B1 (no) 2011-03-21
TWI246925B (en) 2006-01-11
ATE259218T1 (de) 2004-02-15
EP1166773A1 (en) 2002-01-02
HUP0102699A2 (en) 2002-06-29
EP1166773B1 (en) 2004-02-11

Similar Documents

Publication Publication Date Title
EP1018514A4 (en) NF- $ g (k) B INHIBITORS CONTAINING INDANE DERIVATIVES AS ACTIVE INGREDIENT
NO20084390L (no) Substituerte naftylindol-derivater som inhibitorer av plasminogen-aktivatorinhibitor type-1 (PAI-1)
IL172513A0 (en) Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
BR9902086A (pt) Formulações farmacêuticas.
HUP0103318A2 (hu) Eljárás hatóanyagok bevitelére tüdőn keresztül
DK1166773T3 (da) Oplösning indeholdende N-[o-(p-pivaloyloxybenzensulfonylamino)-benzoyl]glycin-mononatriumsalt-tetrahydrat samt medinsk produkt med indhold af denne oplösning
CY1109313T1 (el) Ενωσις φωσφονοκεφεμιου
DE60141815D1 (de) Reagentien zur bestimmung des aktiven sauerstoffs
TWI349674B (en) Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof
EP1291344A4 (en) ACTIVE INGREDIENTS FOR CONTROLLING THE RICE TAN
DE69907258D1 (de) Verfahren zur herstellung von dinatriumpamidronat
DE60106040D1 (de) Verfahren zur herstellung von dinatrium-2,2'-dithiobis(ethansulfonat)
DE69818261D1 (en) Hydroxycyclopentanone
HUP0302826A2 (hu) Szinergetikus hatású herbicid hatóanyag-keverékek és alkalmazásuk
EA200401090A1 (ru) Композиция на основе диклофенака для местного лечения заболеваний орофарингеальной полости
HK1044957B (zh) 二肽基肽酶i的機械定向抑制劑的醫藥應用
DE69900297T2 (de) Akarizid und insektizid wirksame, substituierte Pyrimidine und Verfahren zu ihrer Herstellung
PL1711507T3 (pl) Forma krystaliczna monosodowej soli kwasu rizedronowego
BR9902096A (pt) Pitazóis.
AU4975879A (en) Herbicidal substituted n-pyrazolyl methyl-halogenoacet- anilides
DE69023616T2 (de) Radionukleid-chelatverbindungen zur radiomarkierung von proteinen.
ATE242227T1 (de) Tetrahydrofuranderivate
IL160162A0 (en) Salts of substituted 1,2,3,4,-tetrahydroisoquinolie-2-carboxylic acid derivatives
TR27758A (tr) Asinma önleyici, fosforik veya fosfonik asitlerin metal tuzlarini iceren pigmentler.
AU2003280271A8 (en) Phosphinic acid analogs of glutamate